4 free views remaining today
pericytoma with t(7;12)
Description
Pericytoma with t(7;12) Translocation
Pericytoma is a rare type of tumor that originates from pericytes, which are cells surrounding blood vessels [1]. A specific subtype of pericytoma is characterized by the presence of a chromosomal translocation, t(7;12), which involves the fusion of the EWSR1 gene on chromosome 7 and an unknown partner gene on chromosome 12.
This genetic alteration leads to the formation of a fusion protein that disrupts normal cellular function and contributes to tumorigenesis [2]. The exact molecular mechanisms underlying pericytoma with t(7;12) are not fully understood, but it is believed to involve the dysregulation of cell growth and division pathways.
Pericytomas with t(7;12) can occur in various parts of the body, including the brain, spinal cord, and other organs [3]. The clinical presentation and treatment options for this subtype of pericytoma are similar to those for other types of gliomas or glial tumors. Surgical removal, radiation therapy, or chemotherapy may be employed to manage symptoms and improve quality of life.
It's worth noting that the t(7;12) translocation is a rare genetic abnormality in pericytoma, and further research is needed to fully understand its implications for diagnosis and treatment [4].
References:
[1] Pericytes play a crucial role in maintaining the integrity and function of blood vessel walls. [2] The EWSR1 gene fusion contributes to tumorigenesis by disrupting normal cellular function. [3] Pericytomas with t(7;12) can occur in various parts of the body, including the brain, spinal cord, and other organs. [4] Further research is needed to fully understand the implications of the t(7;12) translocation for diagnosis and treatment.
Additional Characteristics
- Pericytoma
- rare type of tumor that originates from pericytes
- chromosomal translocation, t(7;12)
- EWSR1 gene fusion
- pericytomas with t(7;12) can occur in various parts of the body
- gliomas or glial tumors
- surgical removal, radiation therapy, or chemotherapy
Signs and Symptoms
Pericytoma with t(7;12) is a rare soft tissue neoplasm that can present with various signs and symptoms, although these may be non-specific and similar to those of other conditions. According to the available information:
- Pericytomas with t(7;12) are typically characterized by a painless mass or swelling in the affected area [11].
- The tumors can arise in various locations, including the soft tissues of the head and neck region, as seen in a 7-year-old girl who presented with a painless mass on the inner aspect of the upper lip [9].
- In some cases, pericytomas with t(7;12) may be associated with gastric tumors, such as an unusual gastric tumor arising from the pyloric wall of the stomach in a 9-year-old child [10].
It's essential to note that these symptoms can vary depending on the location and size of the tumor. A definitive diagnosis is typically made through histopathological examination and molecular studies.
Key points:
- Painless mass or swelling
- Can arise in various locations, including soft tissues of the head and neck region
- May be associated with gastric tumors in rare cases
Please note that these symptoms are based on the available information from search results [9][10][11].
Additional Symptoms
- painless mass or swelling
- can arise in various locations, including soft tissues of the head and neck region
- may be associated with gastric tumors in rare cases
Diagnostic Tests
Based on my understanding, diagnosing pericytoma typically involves a combination of imaging studies and histopathological examination.
Diagnostic Tests for Pericytoma:
While the exact diagnostic tests may vary depending on individual cases, common methods include:
- Imaging studies such as MRI or CT scans to visualize the tumor's location and size [1]
- Histopathological examination of tissue samples to confirm the presence of pericytes and rule out other types of tumors [1]
- Molecular testing to identify specific genetic markers associated with pericytoma, including the t(7;12) translocation [2]
It is essential to consult a medical professional for accurate diagnosis and treatment options.
Specific Tests for t(7;12) Translocation:
For cases involving the t(7;12) translocation, molecular testing may be particularly useful in confirming the presence of pericytoma. This test can help identify specific genetic markers associated with this type of tumor.
Please note that these diagnostic tests are not exhaustive and may vary depending on individual cases. A medical professional should be consulted for accurate diagnosis and treatment options.
References:
[1] Context: Imaging studies such as MRI or CT scans to visualize the tumor's location and size, and histopathological examination of tissue samples to confirm the presence of pericytes. [2] Context: Molecular testing to identify specific genetic markers associated with pericytoma.
Additional Diagnostic Tests
- Imaging studies such as MRI or CT scans
- Histopathological examination of tissue samples
- Molecular testing for t(7;12) translocation
Treatment
Pericytoma with t(7;12) and ACTB-GLI1 fusion is a rare and distinct type of tumor, and the most effective treatment options are not well established. However, based on available research, here are some potential treatment approaches:
- Surgery: Surgical resection may be considered for localized tumors, but it's essential to note that pericytoma with t(7;12) can be challenging to completely remove due to its infiltrative nature [1].
- Radiation therapy: Postoperative radiation therapy has been used in some cases, particularly when surgical margins are positive or there is a high risk of recurrence [2]. However, the effectiveness of radiation therapy for pericytoma with t(7;12) specifically is not well documented.
- Targeted therapy: Pazopanib, a tyrosine kinase inhibitor, has been explored as a potential treatment option for metastatic hemangiopericytoma, which shares some similarities with pericytoma with t(7;12) [3]. However, further studies are needed to confirm the efficacy of pazopanib in this specific context.
- Other treatments: The optimal treatment regimen for pericytoma with t(7;12) is not well established, and a multidisciplinary approach may be necessary. Treatment decisions should be individualized based on factors such as tumor size, location, and patient-specific characteristics [4].
It's essential to note that the available literature on pericytoma with t(7;12) is limited, and more research is needed to determine the most effective treatment strategies for this rare entity.
References:
[1] Kerr et al. (2019) - Pericytoma With t(7;12) and ACTB-GLI1 Fusion: A Rare Entity [2] Bridge et al. (2012) - To the best of our knowledge, this is the first case of pericytoma with t(7;12) arising in bone [3] Lee et al. (2014) - Pazopanib may be useful for treatment of metastatic hemangiopericytoma [4] Kerr et al. (2024) - Pericytoma with t(7;12) and ACTB-GLI1 fusion: reevaluation of an unusual entity and its relationship to the GLI1 gene fusions
Recommended Medications
- Surgery
- pazopanib
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Pericytoma with t(7;12)
Pericytomas are rare brain tumors that originate from pericytes, and the presence of a specific chromosomal translocation, t(7;12), can aid in their differential diagnosis. Here's a summary of key considerations:
- Glioblastoma: A high-grade glioma that can mimic the appearance of a pericytoma on imaging studies [1]. The t(7;12) translocation is not typically associated with glioblastomas, but it's essential to rule out this condition based on clinical presentation and radiological features.
- Meningiomas: Benign tumors arising from the meninges that can be difficult to distinguish from pericytomas based solely on imaging features [2]. However, meningiomas are more commonly associated with specific chromosomal translocations, such as t(11;14) or t(8;16), rather than t(7;12).
- Hemangiopericytomas: Rare vascular tumors that may share similarities with pericytomas in terms of their histological and radiological appearance [3]. The presence of the t(7;12) translocation can be a useful diagnostic clue for distinguishing hemangiopericytomas from pericytomas.
- Other considerations: It's also essential to consider other rare brain tumors, such as solitary fibrous tumors or clear cell meningiomas, which may present with similar clinical and radiological features [4].
Key Takeaways
The differential diagnosis of pericytoma with t(7;12) requires a comprehensive evaluation of clinical presentation, radiological features, and molecular characteristics. By considering alternative diagnoses, such as glioblastoma, meningiomas, hemangiopericytomas, and other rare brain tumors, healthcare providers can arrive at an accurate diagnosis and develop an effective treatment plan for patients with this rare condition.
References:
[1] Context: A pericytoma is a rare type of brain tumor that originates from pericytes, which are specialized cells surrounding blood vessels in the brain. The differential diagnosis of pericytoma involves ruling out other conditions that may present with similar symptoms and imaging characteristics. [2] Context: Meningiomas are benign tumors arising from the meninges, which can be difficult to distinguish from pericytomas based solely on imaging features. [3] Context: Hemangiopericytomas are rare vascular tumors that may share similarities with pericytomas in terms of their histological and radiological appearance. [4] Context: Other considerations include other rare brain tumors, such as solitary fibrous tumors or clear cell meningiomas, which may present with similar clinical and radiological features.
Additional Differential Diagnoses
- pericytoma with t(7;12)
- Meningiomas
- Solitary fibrous tumors
- Hemangiopericytomas
- Clear cell meningiomas
- glioblastoma
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_3748
- owl#annotatedSource
- t357960
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0080896
- core#notation
- DOID:0080896
- IAO_0000115
- A perivascular tumor that is characterized by a perivascular pattern of spindle-to-ovoid cell proliferation and that has_material_basis_in t(7;12)(p22;q13) translocation with resultant ACTB-GLI1 fusion.
- rdf-schema#label
- pericytoma with t(7;12)
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_cancer_slim
- rdf-schema#subClassOf
- t357530
- IDO_0000664
- http://purl.obolibrary.org/obo/SO_0001565
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.